These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 23358860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic background dependent modifiers of craniosynostosis severity.
    Dudakovic A, Nam HK, Wijnen AJV, Hatch NE.
    J Struct Biol; 2020 Dec 01; 212(3):107629. PubMed ID: 32976998
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis.
    Wang E, Nam HK, Liu J, Hatch NE.
    Orthod Craniofac Res; 2015 Apr 01; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes.
    Martínez-Abadías N, Motch SM, Pankratz TL, Wang Y, Aldridge K, Jabs EW, Richtsmeier JT.
    Dev Dyn; 2013 Jan 01; 242(1):80-94. PubMed ID: 23172727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Crouzon syndrome mouse model exhibits cartilage hyperproliferation and defective segmentation in the developing trachea.
    Hines EA, Jones MN, Harvey JF, Perlyn C, Ornitz DM, Sun X, Verheyden JM.
    Sci China Life Sci; 2019 Oct 01; 62(10):1375-1380. PubMed ID: 31463736
    [Abstract] [Full Text] [Related]

  • 14. The Fgfr2 W290R mouse model of Crouzon syndrome.
    Gong SG.
    Childs Nerv Syst; 2012 Sep 01; 28(9):1495-503. PubMed ID: 22872266
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Severe craniolacunae and upper and lower extremity anomalies resulting from Crouzon syndrome, FGFR2 mutation, and Ser347Cys variant.
    Raposo-Amaral CE, Oliveira YM, Denadai R, Raposo-Amaral CA, Ghizoni E.
    Childs Nerv Syst; 2021 Jul 01; 37(7):2391-2397. PubMed ID: 33404724
    [Abstract] [Full Text] [Related]

  • 20. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A, Bellosta P, Sahni M, Basilico C.
    J Cell Biol; 2000 Jun 12; 149(6):1297-308. PubMed ID: 10851026
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.